APVO stock forecast
Our latest prediction for Aptevo Therapeutics, Inc.'s stock price was made on the July 29, 2019 when the stock price was at 0.84$.
In the short term (2weeks), APVO's stock price should outperform the market by 6.02%. During that period the price should oscillate between -8.01% and +15.94%.
In the medium term (3months), APVO's stock price should outperform the market by 13.82%. During that period the price should oscillate between -19.28% and +56.21%.Get email alerts
About Aptevo Therapeutics, Inc.
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
At the moment the company generates 27M USD in revenues.
On its last earning announcement, the company reported a loss of -1.88$ per share.
The book value per share is 2.47$
Three months stock forecastJuly 29, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|